In this week's episode, the team provides an in-depth analysis of bond market volatility, key economic data releases, and significant developments across the healthcare and technology sectors. The team discusses evolving rate cut expectations, the implications of new drug pricing initiatives, and the effects of tariffs and permitting reform. Finally, the team review notable corporate earnings, including updates from UnitedHealth, Eli Lilly, and Nvidia.